CPHI

$0.60-2.17%visit website

CHINA PHARMA HOLDINGS, INC.

Market Cap

$26M

Live price × SEC shares (Aug 11, 2026)

Sector

Health Care

Industry

Pharmaceuticals

Beta (raw)

0.93

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

6.6

TTM to Jun 2026 · revenue

P/B

0.7

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	756	1,226	984	948	3,914
Cost of revenue	816	1,075	698	865	3,454
Gross profit	(60)	151	285	84	460
Research & development	40	190	84	19	333
Total operating expenses	568	1,351	1,403	1,515	4,838
Operating income	(628)	(1,200)	(1,117)	(1,432)	(4,377)
Interest expense	6.8	6.9	9.1	9.3	32.1
Pretax income	(651)	(1,222)	(1,143)	(1,458)	(4,475)
Net income	(651)	(1,222)	(1,143)	(1,458)	(4,475)
EPS (basic) ($)	(0.17)		(0.04)	(0.04)	—
EPS (diluted) ($)	(0.17)		(0.04)	(0.04)	—
Weighted avg. shares (basic)	3,874		25,602	40,522
Weighted avg. shares (diluted)			25,602	40,522

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 14, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

6 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Jul 22, 2026 accepted 5:26 PM ET	1.01Material agreement8.01Other events	Document SEC ↗
Mar 3, 2026 accepted 4:05 PM ET	1.01Material agreement3.02Unregistered equity sale	Document SEC ↗
Feb 10, 2026 accepted 4:49 PM ET	1.01Material agreement3.02Unregistered equity sale	Document SEC ↗
Jan 6, 2026 accepted 4:05 PM ET	5.07Shareholder vote	Document SEC ↗
Dec 23, 2025 accepted 4:05 PM ET	1.01Material agreement3.02Unregistered equity sale	Document SEC ↗
Dec 10, 2025 accepted 4:49 PM ET	1.01Material agreement3.02Unregistered equity sale	Document SEC ↗
Apr 4, 2025 accepted 4:05 PM ET	7.01Reg FD disclosure	Document SEC ↗
Dec 26, 2024 accepted 4:30 PM ET	1.02Agreement terminated	Document SEC ↗
Dec 26, 2024 accepted 4:05 PM ET	5.07Shareholder vote	Document SEC ↗
Dec 13, 2024 accepted 8:20 AM ET	1.01Material agreement	Document SEC ↗